China Health Check: CDMOs Preview

Research evidence excerpt

China Health Check: CDMOs Preview

es, only to persons who (i)

are investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the “Order”); (ii) are persons who are

high net worth entities falling within Article 49(2)(a) to (d) of the Order; or (iii) are persons to whom an invitation or inducement to engage in investment activity (within the meaning of section

21 of the Financial Services and Markets Act 2000, as amended) may otherwise lawfully be communicated or caused to be communicated. RMB Morgan Stanley Proprietary Limited is a member

of the JSE Limited and A2X (Pty) Ltd. RMB Morgan Stanley Proprietary Limited is a joint venture owned equally by Morgan Stanley International Holdings Inc. and RMB Investment Advisory

(Proprietary) Limited, which is wholly owned by FirstRand Limited. The information in Morgan Stanley Research is being disseminated by Morgan Stanley Saudi Arabia, regulated by the Capital

Market Authority in the Kingdom of Saudi Arabia, and is directed at Sophisticated investors only.

Morgan Stanley Hong Kong Securities Limited is the liquidity provider/market maker for securities of Akeso, Inc., Alibaba Health Information Technology, CSPC Pharmaceutical Group, Fosun

Pharmaceutical, Innovent Biologics Inc, JD Health International Inc., MicroPort Scientific Corp., Ping An Healthcare and Technology, RemeGen Co., Ltd., Sino Biopharmaceutical, WuXi AppTec

Co Ltd, WuXi Biologics Cayman Inc, WuXi XDC Cayman Inc. listed on the Stock Exchange of Hong Kong Limited. An updated list can be found on HKEx website: http://www.hkex.com.hk.

The information in Morgan Stanley Research is being communicated by Morgan Stanley & Co.